This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Zai Lab Limited (ZLAB) Stock Jumps 6.8%: Will It Continue to Soar?
by Zacks Equity Research
Zai Lab Limited (ZLAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
ZLABNegative Net Change VRTXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Arista Networks (ANET) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ANETNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Figs (FIGS)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FIGSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, GXO Logistics (GXO)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GXONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Anywhere Real Estate (HOUS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HOUSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Synovus Financial (SNV)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SNVNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Skillz (SKLZ) Surges 10.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Skillz (SKLZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SKLZNegative Net Change RBLXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Atmus Filtration Technologies (ATMU) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
ATMUNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Strength Seen in The RealReal (REAL): Can Its 8.8% Jump Turn into More Strength?
by Zacks Equity Research
The RealReal (REAL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
REALNegative Net Change REYNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
GitLab Inc. (GTLB) Just Reclaimed the 50-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
GTLBNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Figs (FIGS) Moves 5.8% Higher: Will This Strength Last?
by Zacks Equity Research
Figs (FIGS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
FIGSNegative Net Change BIRDNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Mitsubishi Heavy Industries (MHVYF) Soars 6.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Mitsubishi Heavy Industries (MHVYF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MHVYFNegative Net Change HLIONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Stratasys (SSYS) Surges 6.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Stratasys (SSYS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SSYSNegative Net Change QUADPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Western Union (WU) Soars 6.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Western Union (WU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
WUNegative Net Change FOURNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in NIO (NIO): Can Its 10.8% Jump Turn into More Strength?
by Zacks Equity Research
NIO (NIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
NIOPositive Net Change HMCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Kohl's (KSS) Surges 37.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Kohl's (KSS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
KSSNegative Net Change DDSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
TTM (TTMI) Surges 5.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
TTM (TTMI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TTMINegative Net Change ROGPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Navitas Semiconductor (NVTS) Surges 24.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Navitas Semiconductor (NVTS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NVTSPositive Net Change CRUSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Astera Labs, Inc. (ALAB): Can Its 19.4% Jump Turn into More Strength?
by Zacks Equity Research
Astera Labs, Inc. (ALAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ALABNegative Net Change EXODNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Should You Buy AXT (AXTI) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
AXTINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength?
by Zacks Equity Research
ABCELLERA BIOLG (ABCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
ABCLNegative Net Change JAZZPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Applied Materials (AMAT) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
AMATNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
SentinelOne (S) Moves 9.8% Higher: Will This Strength Last?
by Zacks Equity Research
SentinelOne (S) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SNegative Net Change QLYSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Beyond (BYON) Moves 22.5% Higher: Will This Strength Last?
by Zacks Equity Research
Beyond (BYON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BYONNegative Net Change EBAYNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CDNANegative Net Change SNDANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today